Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
AMZE - Amaze Holdings Inc - Stock Price Chart
TickerAMZE [AMEX]
CompanyAmaze Holdings Inc
CountryUSA
IndustryBeverages - Wineries & Distilleries
Market Cap55.49MEPS (ttm)-5.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-38.47%
P/S221.97EPS next 5Y-
P/B0.10EPS Q/Q-65.07%
Dividend-Sales Q/Q-42.42%
Insider Own64.64%Inst Own0.38%
Insider Trans2.21%Inst Trans-
Short Float0.47%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume33.19K52W Range5.78 - 28.72
Amaze Holdings, Inc. produces low carb and calorie premium wines. Its varietals currently include Cabernet Sauvignon, Chardonnay, Pinot Noir and Rose. The firm sales channels include wholesale, retail, and direct-to-consumer (DTC) channels able to conduct wholesale distribution of wine in all 50 states and Puerto Rico. Its wholesale distribution network includes 30 distributors, including a distribution agreement with Southern Glazer's Wine and Spirits. The company was founded by Julianne Hough, Nina Dobrev, Rick Nechio and Damian Novak in May 2019 and is headquartered in Newport Beach, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Day AaronDirectorJun 10 '25Buy0.4473,71632,22173,716Jun 12 06:39 PM
MTSR - Metsera Inc - Stock Price Chart
TickerMTSR [NASD, RUT]
CompanyMetsera Inc
CountryUSA
IndustryBiotechnology
Market Cap3.71BEPS (ttm)-
P/E-EPS this Y77.77%
Forward P/E-EPS next Y-8.62%
PEG-EPS past 5Y-
P/S-EPS next 5Y32.63%
P/B7.33EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own51.74%Inst Own38.81%
Insider Trans10.66%Inst Trans85.41%
Short Float17.41%EarningsMay 12/b
Analyst Recom1.00Target Price55.00
Avg Volume1.03M52W Range12.30 - 37.99
Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burow KristinaDirectorFeb 03 '25Buy18.002,222,22239,999,99618,503,128Feb 03 07:15 PM
BERNS PAUL LDirectorFeb 03 '25Buy18.00789,99814,219,9648,313,680Feb 03 07:04 PM
ARCH Venture Partners XII, LLC10% OwnerFeb 03 '25Buy18.002,222,22239,999,99618,503,128Feb 03 07:01 PM
VVOS - Vivos Therapeutics Inc - Stock Price Chart
TickerVVOS [NASD]
CompanyVivos Therapeutics Inc
CountryUSA
IndustryMedical Devices
Market Cap35.34MEPS (ttm)-1.92
P/E-EPS this Y36.04%
Forward P/E-EPS next Y34.51%
PEG-EPS past 5Y32.77%
P/S2.42EPS next 5Y-
P/B8.02EPS Q/Q72.42%
Dividend-Sales Q/Q-11.79%
Insider Own36.08%Inst Own4.79%
Insider Trans0.00%Inst Trans-17.50%
Short Float8.17%EarningsMay 15/a
Analyst Recom2.00Target Price4.22
Avg Volume675.95K52W Range1.97 - 6.28
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
MBIO - Mustang Bio Inc - Stock Price Chart
TickerMBIO [NASD]
CompanyMustang Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap13.62MEPS (ttm)-20.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y51.52%
P/S-EPS next 5Y-
P/B2.91EPS Q/Q99.77%
Dividend-Sales Q/Q-
Insider Own28.11%Inst Own2.62%
Insider Trans0.00%Inst Trans-55.73%
Short Float0.12%Earnings-
Analyst Recom1.00Target Price500.00
Avg Volume5.63M52W Range0.89 - 24.00
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.
XIFR - XPLR Infrastructure LP - Stock Price Chart
TickerXIFR [NYSE]
CompanyXPLR Infrastructure LP
CountryUSA
IndustryUtilities - Renewable
Market Cap1.84BEPS (ttm)-1.89
P/E-EPS this Y2485.79%
Forward P/E4.69EPS next Y-20.36%
PEG-EPS past 5Y30.31%
P/S1.49EPS next 5Y-
P/B0.30EPS Q/Q-239.70%
Dividend18.58%Sales Q/Q10.12%
Insider Own7.95%Inst Own48.04%
Insider Trans0.00%Inst Trans5.48%
Short Float5.40%EarningsMay 08/a
Analyst Recom3.15Target Price11.55
Avg Volume1.16M52W Range7.53 - 29.03
XPLR Infrastructure LP engages in the acquisition, management, and ownership of contracted clean energy projects with long-term cash flows. It owns interests in wind and solar projects in North America and natural gas infrastructure assets in Texas. The company was founded on March 6, 2014 and is headquartered in Juno Beach, FL.
PROK - ProKidney Corp - Stock Price Chart
TickerPROK [NASD]
CompanyProKidney Corp
CountryUSA
IndustryBiotechnology
Market Cap1.27BEPS (ttm)-0.60
P/E-EPS this Y21.23%
Forward P/E-EPS next Y-17.88%
PEG-EPS past 5Y-
P/S4097.77EPS next 5Y-2.42%
P/B-EPS Q/Q16.70%
Dividend-Sales Q/Q-
Insider Own27.29%Inst Own41.58%
Insider Trans2.80%Inst Trans-3.65%
Short Float17.84%EarningsMay 12/a
Analyst Recom2.29Target Price4.60
Avg Volume6.75M52W Range0.46 - 4.92
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weber Darin J.Chief Regulatory OfficerJul 08 '25Sale3.02103,480312,5100Jul 09 04:28 PM
DARIN J WEBEROfficerJul 08 '25Proposed Sale0.61103,48062,761Jul 08 04:20 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 22 '25Buy0.71387,393276,36673,842,723Apr 24 04:15 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 17 '25Buy0.7525,00018,69073,455,330Apr 21 04:37 PM
Control Empresarial de CapitalAdd'l Rep. Persons-see Ex.99-1Apr 16 '25Buy0.75100,00074,82073,430,330Apr 18 04:15 PM
CADL - Candel Therapeutics Inc - Stock Price Chart
TickerCADL [NASD, RUT]
CompanyCandel Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap324.74MEPS (ttm)-1.34
P/E-EPS this Y74.90%
Forward P/E-EPS next Y-54.96%
PEG-EPS past 5Y-43.86%
P/S-EPS next 5Y56.83%
P/B4.02EPS Q/Q147.83%
Dividend-Sales Q/Q-
Insider Own31.18%Inst Own35.85%
Insider Trans-1.66%Inst Trans19.03%
Short Float17.06%EarningsMay 13/b
Analyst Recom1.00Target Price21.00
Avg Volume924.14K52W Range3.79 - 14.60
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nichols William GarrettChief Medical OfficerJun 30 '25Option Exercise1.297811,00753,274Jul 02 04:30 PM
Nichols William GarrettChief Medical OfficerJun 30 '25Sale5.047813,93652,493Jul 02 04:30 PM
WILLIAM GARRETT NICHOLSOfficerJun 30 '25Proposed Sale4.903,59317,606Jun 30 04:19 PM
Nichols William GarrettChief Medical OfficerMar 18 '25Option Exercise1.9018,48935,12797,809Mar 20 04:36 PM
Nichols William GarrettChief Medical OfficerMar 18 '25Sale8.7645,316396,99552,493Mar 20 04:36 PM
JLHL - Julong Holding Ltd - Stock Price Chart
TickerJLHL [NASD]
CompanyJulong Holding Ltd
CountryChina
IndustryBuilding Products & Equipment
Market Cap83.22MEPS (ttm)0.21
P/E18.48EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-4.70%
Dividend-Sales Q/Q-1.30%
Insider Own88.80%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume306.52K52W Range3.05 - 6.30
Julong Holding Limited provides intelligent integrated services and solutions to various infrastructure projects in China. It engages in the design, procurement, installation, integration, and maintenance of the security, access control, and parking systems; installation, integration, and maintenance of the parking and visitor management systems; operation and maintenance of the intelligent integrated systems; and sale of equipment and materials of intelligent systems. The company serves private and public sector clients that include public utilities, and commercial and multifamily residential properties. The company was founded in 1997 and is headquartered in Beijing, China. Julong Holding Limited is a subsidiary of Datongyi Holding Limited.
NAK - Northern Dynasty Minerals Ltd - Stock Price Chart
TickerNAK [AMEX]
CompanyNorthern Dynasty Minerals Ltd
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap1.13BEPS (ttm)-0.09
P/E-EPS this Y-7.09%
Forward P/E-EPS next Y66.66%
PEG-EPS past 5Y19.53%
P/S-EPS next 5Y24.65%
P/B28.48EPS Q/Q-616.44%
Dividend-Sales Q/Q-
Insider Own1.99%Inst Own10.16%
Insider Trans0.00%Inst Trans-10.25%
Short Float3.11%EarningsMay 14/a
Analyst Recom1.00Target Price2.50
Avg Volume7.62M52W Range0.30 - 1.83
Northern Dynasty Minerals Ltd. engages in the exploration and development of gold and copper mineral properties. It holds interest in the Pebble Copper-Gold-Molybdenum Project, which is an undeveloped copper-gold-molybdenum-silver resource. The company was founded on May 11, 1983 and is headquartered in Vancouver, Canada.
NEGG - Newegg Commerce Inc - Stock Price Chart
TickerNEGG [NASD]
CompanyNewegg Commerce Inc
CountryUSA
IndustryInternet Retail
Market Cap421.29MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y43.78%
P/S-EPS next 5Y-
P/B-EPS Q/Q-364.23%
Dividend-Sales Q/Q-27.42%
Insider Own97.12%Inst Own0.44%
Insider Trans0.00%Inst Trans16.78%
Short Float64.46%EarningsApr 28/b
Analyst Recom1.00Target Price60.00
Avg Volume548.71K52W Range3.32 - 24.20
Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tekhill USA LLCDirectorMay 22 '25Proposed Sale6.00950,0005,700,000May 22 04:40 PM
TEKHILL USA LLCAffiliateMay 01 '25Proposed Sale3.6823,10085,008May 01 04:05 PM
Yang YingmeiDirectorApr 21 '25Proposed Sale3.93109428Apr 21 10:20 AM
Yang YingmeiDirectorApr 17 '25Proposed Sale3.78150567Apr 17 09:45 AM
Yang YingmeiDirectorApr 16 '25Proposed Sale3.95150592Apr 16 10:18 AM
123456789101120